Donghong Li

Donghong Li

Auto-generated profile, based on publicly available information

Donghong Li

College of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2024 in Reliability Engineering & System Safety
Verified
Journal Article
Closed access
XZXi Zhang
Xi Zhang
QWQin Wang
Qin Wang
XBXiaowen Bi
Xiaowen Bi
DLDonghong Li
Donghong Li
DLDong Liu
Dong Liu
CTChi K. Tse
Chi K. Tse

1 May 2024 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
CCChun-Hui Chang
Chun-Hui Chang
DHDe-En Han
De-En Han
YJYu-Ying Ji
Yu-Ying Ji
MWMengyan - Wang
Mengyan - Wang
DLDong-Hong Li
Dong-Hong Li
YJYong-Yan Jia
Yong-Yan Jia
Background: Although quercetin exhibits promising anti-tumor properties, its clinical application is limited due to inherent defects and a lack of tumor targeting. Objective: This study aimed to prepare and characterize active targeting folate-chitosan modified quercetin liposomes (FA-CS-QUE-Lip), and its antitumor activity in vitro and in vivo was also studied. Materials and Methods: Box-Behnken Design (BBD) response surface method was used to select the optimal formulation of quercetin liposomes (QUE-LP). On this basis, FA-CS-QUE-LP was obtained by connecting folic acid chitosan complex (FA-CS) and QUE-LP. The release characteristics in vitro of QUE-LP and FA-CS-QUE-LP were studied. Its inhibitory effects on HepG2 cells were studied by the MTT method. The pharmacokinetics and pharmacodynamics in vivo were studied in healthy Wistar mice and S180 tumor-bearing mice, respectively. Results: The average particle size, zeta potential and encapsulation efficiency of FA-CS-QUELP were 261.6 ± 8.5 nm, 22.3 ± 1.7 mV, and 98.63 ± 1.28 %, respectively. FA-CS-QUE-LP had a sustained release effect and conformed to the Maloid-Banakar release model (R2=0.9967). The results showed that FA-CS-QUE-LP had higher inhibition rates on HepG2 cells than QUE-Sol (P < 0.01). There was a significant difference in AUC, t1/2, CL and other pharmacokinetic parameters among QUE-LP, FA-CS-QUE-LP, and QUE-Sol (P < 0.05). In in vivo antitumor activity study, the weight inhibition rate and volume inhibition rate of FA-CS-QUE-LP were 30.26% and 37.35%, respectively. Conclusion: FA-CS-QUE-LP exhibited a significant inhibitory effect on HepG2 cells, influenced the pharmacokinetics of quercetin in mice, and demonstrated a certain inhibitory effect on S180 tumor-bearing mice, thus offering novel avenues for cancer treatment.

27 February 2024 in Biomacromolecules
Verified
Journal Article
Closed access
DLDonghong Li
Donghong Li
QLQinglin Li
Qinglin Li
TXTingting Xu
Tingting Xu
XGXuran Guo
Xuran Guo
HTHan Tang
Han Tang
YZYanzhong Zhang
Yanzhong Zhang

28 November 2024 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
DLDonghong Li
Donghong Li
TXTingting Xu
Tingting Xu
XWXiaoli Wang
Xiaoli Wang
QXQiong Xiao
Qiong Xiao
WZWenjie Zhang
Wenjie Zhang
YZYanzhong Zhang
Yanzhong Zhang
Regeneration of functional bone tissue relies heavily on achieving adequate vascularization in engineered bone constructs following implantation. This process requires the close integration of osteogenesis and angiogenesis. Cell-free fat extract (CEFFE or FE), a recently emerging acellular fat extract containing abundant growth factors, holds significant potential for regulating osteo–angiogenic coupling and promoting regeneration of vascularized bone tissue. However, its specific role in modulating the coupling between angiogenesis and osteogenesis remains unclear. Our previous research demonstrated that FE-decorated electrospun fibers of polycaprolactone/gelatin (named FE-PDA@PCL/GT) exhibited pro-vasculogenic capabilities both in vitro and in vivo (D. Li, Q. Li, T. Xu, X. Guo, H. Tang, W. Wang, W. Zhang and Y. Zhang, Pro-vasculogenic fibers by PDA-mediated surface functionalization using cell-free fat extract (CEFFE), Biomacromolecules 2024, 25, 1550–1562). Herein, we firstly demonstrated that the FE-PDA@PCL/GT fibers also significantly stimulated osteogenesis in a mouse calvaria osteoblast-like cell line MC3T3-E1 cells, as evidenced by the increased production of alkaline phosphatase (ALP), mineral deposits, and collagen I, as well as the upregulated expression of osteogenic marker genes in the osteoblasts. Using a transwell co-culture system, we further demonstrated that the release of FE from the FE-PDA@PCL/GT fibers not only promoted osteogenesis and angiogenesis but also markedly enhanced the paracrine functions and reciprocal communications between endothelial cells and osteoblasts. This dynamic interaction played a key role in the observed enhancement of osteo–angiogenic coupling. With the confirmed pro-osteogenic and pro-angiogenic properties of FE-PDA@PCL/GT, it is envisaged that these newly engineered bioactive fibers can be used to develop highly biomimicking bone constructs. These constructs are designed to promote native-like cell–scaffold and cell–cell interactions, which are essential for the effective regeneration of defected bone tissue with adequate vasculature.